As the downstream gene of the pathway, numerous reports have implicated GLI2 in the regulation of human carcinogenesis by inducing cancer cell malignant phenotypes, suggesting the potential of GLI2 as a new target for cancer treatment [13]. The gene discussed is GLI2; the disease is cancer.